NYSE:AVNS - Avanos Medical Stock Price, Forecast & News

Avanos Medical trades on the New York Stock Exchange (NYSE) under the ticker symbol "AVNS."

Avanos Medical Inc (NYSE:AVNS) issued its earnings results on Tuesday, November, 5th. The company reported $0.30 EPS for the quarter, missing the Thomson Reuters' consensus estimate of $0.32 by $0.02. The business had revenue of $171.40 million for the quarter, compared to the consensus estimate of $179.98 million. Avanos Medical had a positive return on equity of 3.92% and a negative net margin of 6.20%. The business's revenue was up 3.8% compared to the same quarter last year. During the same quarter in the prior year, the firm posted $0.37 earnings per share. View Avanos Medical's Earnings History.

Avanos Medical is scheduled to release their next quarterly earnings announcement on Tuesday, February 25th 2020. View Earnings Estimates for Avanos Medical.

Avanos Medical updated its FY19 earnings guidance on Tuesday, November, 5th. The company provided earnings per share guidance of $1.00-1.10 for the period, compared to the Thomson Reuters consensus EPS estimate of $1.19. The company issued revenue guidance of +5-7% yr/yr to ~$685-698 million, compared to the consensus revenue estimate of $708.11 million.

5 analysts have issued 12 month target prices for Avanos Medical's shares. Their forecasts range from $32.00 to $65.00. On average, they expect Avanos Medical's stock price to reach $45.00 in the next twelve months. This suggests a possible upside of 50.2% from the stock's current price. View Analyst Price Targets for Avanos Medical.

5 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Avanos Medical in the last year. There are currently 1 sell rating, 3 hold ratings and 1 buy rating for the stock, resulting in a consensus recommendation of "Hold." View Analyst Ratings for Avanos Medical.

News coverage about AVNS stock has trended somewhat negative this week, InfoTrie reports. The research firm identifies negative and positive media coverage by reviewing more than six thousand blog and news sources in real-time. The firm ranks coverage of companies on a scale of negative five to five, with scores closest to five being the most favorable. Avanos Medical earned a media sentiment score of -1.0 on InfoTrie's scale. They also assigned news coverage about the company a news buzz of 10.0 out of 10, indicating that recent media coverage is extremely likely to have an effect on the company's share price in the near future. View News Stories for Avanos Medical.

Some companies that are related to Avanos Medical include MSA Safety (MSA), Wound Management Technologies (WNDM), Wright Medical Group (WMGI), Inogen (INGN), Establishment Labs (ESTA), Sientra (SIEN), RTI Surgical (RTIX), Invacare (IVC), Lakeland Industries (LAKE), ConforMIS (CFMS), Histogenics (HSGX), COLLPLANT HOLDI/S (CLGN), Rewalk Robotics (RWLK), NanoVibronix (NAOV) and Ocugen (OCGN).

Based on aggregate information from My MarketBeat watchlists, some companies that other Avanos Medical investors own include Kimberly Clark (KMB), Alibaba Group (BABA), CVS Health (CVS), Home Depot (HD), Honeywell International (HON), Procter & Gamble (PG), AT&T (T), Verizon Communications (VZ), Cisco Systems (CSCO) and Thermo Fisher Scientific (TMO).

Avanos Medical's stock is owned by a variety of of institutional and retail investors. Top institutional shareholders include Diversified Trust Co (0.03%), State of Alaska Department of Revenue (0.02%), Somerset Trust Co (0.01%) and Nisa Investment Advisors LLC (0.01%). Company insiders that own Avanos Medical stock include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Institutional Ownership Trends for Avanos Medical.

AVNS stock was sold by a variety of institutional investors in the last quarter, including Nisa Investment Advisors LLC, Somerset Trust Co and State of Alaska Department of Revenue. View Insider Buying and Selling for Avanos Medical.

AVNS stock was purchased by a variety of institutional investors in the last quarter, including Diversified Trust Co. Company insiders that have bought Avanos Medical stock in the last two years include John W Wesley, Joseph Fralin Woody and Steven E Voskuil. View Insider Buying and Selling for Avanos Medical.

Shares of AVNS can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity and Charles Schwab.

One share of AVNS stock can currently be purchased for approximately $29.97.

Avanos Medical has a market capitalization of $1.44 billion and generates $652.30 million in revenue each year. The company earns $57.50 million in net income (profit) each year or $0.82 on an earnings per share basis. Avanos Medical employs 4,700 workers across the globe.View Additional Information About Avanos Medical.

The official website for Avanos Medical is http://www.halyardhealth.com/.

Avanos Medical's mailing address is 5405 Windward Parkway Suite 100 South, Alpharetta GA, 30004. The company can be reached via phone at 844-428-2667 or via email at [email protected]